Ying Wang
Sun Yat-sen University
12 Papers
6 Citations
Ying Wang is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Breast cancer & Metastatic breast cancer. The author has an hindex of 6, co-authored 12 publications.
Chat about Author
Papers
Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer.
TL;DR: It is demonstrated that miR-21 expression was up-regulated and its function was elevated in HER2+ BT474, SKBR3, and MDA-MB-453 breast cancer cells that are induced to acquire trastuzumab resistance by long-term exposure to the antibody, whereas protein expression of the PTEN gene, a miR -21 target, was reduced.
321
MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells.
Fengyan Yu,Yu Jiao,Yinghua Zhu,Ying Wang,Jingde Zhu,Xiuying Cui,Yujie Liu,Yinghua He,Eun Young Park,Hongyu Zhang,Xiao-Bin Lv,Kelong Ma,Fengxi Su,Jong Hoon Park,Erwei Song +14 more
TL;DR: In this paper, the expression and function of miR-34c were reduced in the BT-ICs of MCF-7 and SK-3rd cells, a breast cancer cell line enriched for BTICs.
148
Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
Jieqiong Liu,Qiang Liu,Ying Li,Qian Li,Fengxi Su,Herui Yao,Shicheng Su,Quanren Wang,Liang Jin,Ying Wang,Wan Yee Lau,Zefei Jiang,Erwei Song +12 more
TL;DR: Camrelizumab combined with apatinib demonstrated favorable therapeutic effects and a manageable safety profile in patients with advanced TNBC and the ORR was dramatically higher than previously reported ORR by anti-PD-1/PD-L1 antibody or apatinIB monotherapy.
141
Comparison of the Therapeutic Efficacy of the Early and the Delayed Use of Vinorelbine-Based Regimens for Patients with Advanced Breast Cancer
TL;DR: For ABC patients, no significant difference in median OS was found between the early use and delayed use of vinorelbine-based regimens, but the short-term efficacy and PFS were significantly better in theEarly use group than in the delayed use group.
7
Multiple metastases of bones and sigmoid colon after mastectomy for ductal carcinoma in situ of the breast: a case report
Qiuting You,Yichao Fang,Chenchen Li,Yujie Tan,Jianli Zhao,Cui Tan,Ying Wang,Herui Yao,Fengxi Su +8 more
TL;DR: This case reveals the heterogeneous behavior and the potential poor outcome of DCIS, regular examination and surveillance are necessary even though the distant metastasis rate in DCIS is low.